Back
Riley Exploration Permian Vs. Denali Therapeutics Industry Stock Comparison
Buy
54
REPX
Riley Exploration Permian
Last Price:
27.06
Seasonality Move:
-8.52%
Buy
56
DNLI
Denali Therapeutics
Last Price:
30.74
Seasonality Move:
17.79%
Buy
54
Riley Exploration Permian (REPX)
is a Buy
Is Riley Exploration Permian a Buy, Sell or Hold?
- The current Riley Exploration Permian [REPX] share price is $27.38. The Score for REPX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- REPX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.68. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REPX Stock Price Chart
What is Riley Exploration Permian's stock price today?
-
The Riley Exploration Permian share price today is $27.38
The current trend is relatively stagnant and REPX is experiencing buying pressure, which is a positive indicator for future bullish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.
REPX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 53.72 | Buy |
| Chaikin Money Flow: | 68546 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.86 - 28.26) | Buy |
| Bollinger Bands (100): | (25.78 - 28.74) | Buy |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.67 | Buy |
| Relative Strength Index (14 RSI): | 77.92 | Buy |
| Chaikin Money Flow: | 34344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.24 - 27.72) | Buy |
| Bollinger Bands (100): | (18.96 - 25.08) | Buy |
REPX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.86 | Buy |
| 20-day SMA: | 26.94 | Buy |
| 50-day SMA: | 27.56 | Sell |
| 200-day SMA: | 26.71 | Buy |
| 8-day EMA: | 26.41 | Buy |
| 20-day EMA: | 26.67 | Buy |
| 50-day EMA: | 27.13 | Buy |
| 200-day EMA: | 27.76 | Sell |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28 | Buy |
| 20-day SMA: | 26.04 | Buy |
| 50-day SMA: | 24.18 | Buy |
| 200-day SMA: | 20.53 | Buy |
| 8-day EMA: | 28.54 | Buy |
| 20-day EMA: | 26.57 | Buy |
| 50-day EMA: | 24.56 | Buy |
| 200-day EMA: | 22.12 | Buy |
Riley Exploration Permian Earnings Growth & REPX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.45 per share, an increase this year of $0.71 per share, and an increase next year of $1.11 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Riley Exploration Permian Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||